ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir
in combination with chemoradiation for locally advanced inoperable
pancreatic cancer

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

Background and purpose Nelfinavir can enhance intrinsic radiosensitivity, reduce hypoxia and improve vascularity. We conducted a phase II trial combining nelfinavir with chemoradiotherapy (CRT) for locally advanced inoperable pancreatic cancer (LAPC). Materials and methods Radiotherapy (50.4 Gy/28...

Полное описание

Библиографические подробности
Главные авторы:	Wilson, J, Fokas, E, Dutton, S, Hawkins, M, al., E
Формат:	Journal article
Опубликовано:	Elsevier 2016

Схожие документы

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
по: Wilson, J, и др.
Опубликовано: (2017)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
по: Brunner, T, и др.
Опубликовано: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
по: Brunner, T, и др.
Опубликовано: (2008)

Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
по: Brunner, T, и др.
Опубликовано: (2008)

HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment
по: Unaí Tupinambás, и др.

New insights into the in silico prediction of HIV protease resistance to nelfinavir.
по: Dinler A Antunes, и др.
Опубликовано: (2014-01-01)

Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
по: Chao Ying, и др.
Опубликовано: (2008-02-01)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
по: Holyoake, D, и др.
Опубликовано: (2016)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
по: Crosby, T, и др.
Опубликовано: (2004)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
по: Anjali K. Gupta, и др.
Опубликовано: (2007-04-01)

Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes.
по: Pranav Kumar, и др.
Опубликовано: (2010-03-01)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
по: Mukherjee, S, и др.
Опубликовано: (2024)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
по: Zhongli Liu, и др.
Опубликовано: (2022-08-01)

Pneumocephalus after the Treatment of an Inoperable Superior Sulcus Tumor with Chemoradiation
по: Ashley Albert, и др.
Опубликовано: (2017-01-01)

The impact of the nelfinavir resistance-conferring mutation D30N on the susceptibility of HIV-1 subtype B to other protease inhibitors
по: André FA Santos, и др.
Опубликовано: (2011-03-01)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
по: Mukherjee, S, и др.
Опубликовано: (2018)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
по: Al-Assar, O, и др.
Опубликовано: (2016)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
по: Sudeep Gupta, и др.
Опубликовано: (2022-04-01)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
по: Fokas, E, и др.
Опубликовано: (2013)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
по: Steffi Liebscher, и др.
Опубликовано: (2017-02-01)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
по: E. P. Solov’eva, и др.
Опубликовано: (2016-02-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
по: Christoph Driessen, и др.
Опубликовано: (2016-03-01)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
по: V. B. Denisenko,, и др.
Опубликовано: (2018-12-01)

Chemoradiation of pancreatic carcinoma
по: Erdinç Nayır, и др.
Опубликовано: (2016-08-01)

Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients
по: Jean-Guy Baril, и др.
Опубликовано: (2003-01-01)

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
по: Camille Bono, и др.
Опубликовано: (2012-07-01)

Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation
по: Hilario Yankey, MD, MBA, и др.
Опубликовано: (2024-04-01)

Combination of chemoradiation therapy with immunotherapy in the treatment of patients with inoperable stage III non-small cell lung cancer
по: N. V. Marinichenko, и др.
Опубликовано: (2020-12-01)

Spectrophometric Determination of Nelfinavir Mesylate
по: K. Vanitha Prakash, и др.
Опубликовано: (2006-01-01)

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study
по: Alison K. Yoder, и др.
Опубликовано: (2021-07-01)

ACCELEREATED HYPERFRACTIONATED WITH UNEVEN CRUSHING DAILY DOSE WITH CHEMORADIATION TREATMENT OF INOPERABLE NON-SMALL CELL LUNG CANCER.
по: D. V. Gogolin, и др.
Опубликовано: (2016-02-01)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
по: Léon Juan, и др.
Опубликовано: (2006-07-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
по: Rosi Bissinger, и др.
Опубликовано: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
по: Lenka Besse, и др.
Опубликовано: (2023-03-01)

Nelfinavir: An Old Ally in the COVID-19 Fight?
по: Anna Gidari, и др.
Опубликовано: (2022-12-01)

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
по: Serena Veschi, и др.
Опубликовано: (2018-09-01)

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
по: Kang Young-Nam, и др.
Опубликовано: (2010-06-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
по: Hill, E, и др.
Опубликовано: (2016)

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
по: Tinkl, D, и др.
Опубликовано: (2009)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
по: Camacho Ricardo J, и др.
Опубликовано: (2010-08-01)